Ikeda T, Nonaka Y, Goto A, Ishii M
Clin Pharmacol Ther. 1985 Jun;37(6):601-5. doi: 10.1038/clpt.1985.95.
Platelet aggregation in response to adenosine 5'-diphosphate (ADP) and plasma levels of beta-thromboglobulin (beta-TG) were followed in 10 subjects with essential hypertension without any manifest vascular complications and in 14 age-matched normotensive controls. The effects of prazosin on blood pressure and platelet function were also examined in the subjects with hypertension. Platelet aggregation in response to 5 microM ADP was significantly greater in the subjects with hypertension than in the controls. Plasma beta-TG levels were 30% higher in the subjects with hypertension than in the controls. The increased platelet aggregation and plasma levels of beta-TG in the subjects with hypertension returned to normal after the blood pressure had been controlled by prazosin therapy. Our data suggest that the aggregation and release reactions of platelets increase in uncomplicated essential hypertension, and that prazosin may have some beneficial effects on the prevention of vascular complications in hypertension by normalizing platelet function as well as by lowering blood pressure.
对10名无明显血管并发症的原发性高血压患者和14名年龄匹配的血压正常对照者,随访观察了二磷酸腺苷(ADP)诱导的血小板聚集情况及血浆β-血小板球蛋白(β-TG)水平。同时,也对高血压患者中哌唑嗪对血压和血小板功能的影响进行了研究。高血压患者对5微摩尔ADP诱导的血小板聚集显著高于对照组。高血压患者血浆β-TG水平比对照组高30%。经哌唑嗪治疗控制血压后,高血压患者血小板聚集增加及血浆β-TG水平升高恢复正常。我们的数据表明,在无并发症的原发性高血压中血小板的聚集和释放反应增强,并且哌唑嗪可能通过使血小板功能正常化以及降低血压,对预防高血压血管并发症具有一定的有益作用。